Dazostinag

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H22F2N8O10P2S2
Molecular Weight	710.521
Optical Activity	UNSPECIFIED
Defined Stereocenters	10 / 10
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]12CO[P@](S)(=O)O[C@@]3([H])[C@@H](F)[C@@H](O[C@]3([H])CO[P@](S)(=O)O[C@]([H])([C@@H]1O)[C@@H](O2)N4C=C(F)C5=C4NC=NC5=O)N6C=NC7=C(N)N=CN=C67

InChI

InChIKey=SIIGKCBSQKWSLM-RNPBXGGWSA-N

InChI=1S/C21H22F2N8O10P2S2/c22-7-1-30(17-10(7)19(33)28-5-26-17)21-15-13(32)8(38-21)2-36-42(34,44)40-14-9(3-37-43(35,45)41-15)39-20(11(14)23)31-6-29-12-16(24)25-4-27-18(12)31/h1,4-6,8-9,11,13-15,20-21,32H,2-3H2,(H,34,44)(H,35,45)(H2,24,25,27)(H,26,28,33)/t8-,9-,11-,13-,14-,15-,20-,21-,42-,43-/m1/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

Dazostinag

Official Name

English

dazostinag [INN]

Common Name

English

7-Deazainosine, [P(R)]-2′-deoxy-2′-fluoro-5′-O-[(R)-hydroxymercaptophosphinyl]-P-thioadenylyl-(3′→5′)-7-fluoro-, cyclic (2′→5′)-nucleotide

Systematic Name

English

Code System Code Type Description

FDA UNII

W4RT71M1YD